Aqr Capital Management LLC Accelerate Diagnostics, Inc Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $8,498 - $22,190	-15,738 Reduced 35.9%	28,097 $28,000
Q1 2022 May 16, 2022	BUY	$1.4 - $5.15 $61,368 - $225,750	43,835 New	43,835 $63,000
Q1 2018 May 15, 2018	SELL	$22.55 - $29.9 $174,514 - $231,396	-7,739 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $198,900 - $331,500	-11,050 Reduced 58.81%	7,739 $203,000
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $396,447 - $472,543	18,789	18,789 $422,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.